September 28, 2020
September 28, 2020
Categories

Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial (The Lancet)

The Lancet Date: 28 September, 2020 Alexander P J Vlaar, Sanne de Bruin, Matthias Busch, Sjoerd A M E G Timmermans, Ingeborg E van Zeggeren, Rutger […]
Do you like it?
Read more
September 25, 2020
September 25, 2020
Categories

Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study (The Lancet)

The Lancet Date: 25 September, 2020 Brandon J Webb, Ithan D Peltan,Paul Jensen, Daanish Hoda, Bradley Hunter, Aaron Silver, Nathan Starr, Whitney Buckel, Nancy Grisel, Erika […]
Do you like it?
Read more
September 25, 2020
September 25, 2020
Categories

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study (The Lancet)

The Lancet 25 September, 2020 Shuchi Anand, MD, Maria Montez-Rath, PhD, Jialin Han, MS, Julie Bozeman, CLS, Russell Kerschmann, MD, Paul Beyer, MBA et al. Severe […]
Do you like it?
Read more
September 25, 2020
September 25, 2020
Categories

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study (The Lancet)

The Lancet 25 September, 2020 Bernadette Schurink, PhD, Eva Roos, PhD, Teodora Radonic, PhD, Ellis Barbe, PhD Catherine S C Bouman, PhD, Hans H de Boer, […]
Do you like it?
Read more
September 25, 2020
September 25, 2020
Categories

Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry (The Lancet)

The Lancet 25 September, 2020 Ryan P Barbaro, MD, Graeme MacLaren, MBBS, Philip S Boonstra, PhD, Prof Theodore J Iwashyna, MD, Prof Arthur S Slutsky, MD, […]
Do you like it?
Read more
September 16, 2020
September 16, 2020
Categories

Covid-19 pandemic: Tiny antibody completely neutralises novel coronavirus

Published in: The Business Standard Date: 16 September, 2020 Ten times smaller than a full-sized antibody, the molecule has been used to construct a drug — […]
Do you like it?
Read more
September 14, 2020
September 14, 2020
Categories

Researchers trial inhaled versions of Oxford and Imperial Covid-19 vaccine candidates

Published in: The Business Standard Date: 14 September, 2020 The Oxford and Imperial vaccines are both being tested in trials through intramuscular injection, but scientists from […]
Do you like it?
Read more
September 11, 2020
September 11, 2020
Categories

Millions of Covid-19 cases went undetected in India, research paper estimates

Published in: The Business Standard Date: 11 September, 2020 The paper, published in the Indian Journal of Medical Research, estimated that the country had nearly 6.5 […]
Do you like it?
Read more
September 4, 2020
September 4, 2020
Categories

Results of Russia’s COVID-19 vaccine produced antibody response (The Lancet)

Reuters Andrew Osborn and Polina Ivanova 04 September, 2020 Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results […]
Do you like it?
Read more
Load more